Home
Inbox
Search
Speaker
David Lamb
PhD
Boehringer Ingelheim Pharma GmbH & Co. KG
Bookmark
Session(s)
The Potential for RORgamma Antagonists to Treat A Sub-Population of Severe Asthma: A Trans...
Wednesday, May 23
9:15 AM - 9:30 AM
Home
Inbox
Search